Click on image to view larger version.

Figure 4 The administration of NCX-4016 either alone or in combination with aspirin (ASA) reduced the secretion of monocyte chemoattractant protein-1 (MCP-1) (A), interleukin-6 (IL-6) (B), and expression of CD11b (C and D) compared with placebo and ASA alone. n = 12. *p < 0.05 vs. placebo and ASA alone.